Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanza
SEBI is in focus in a corporate actions development.
· ET Stocks, Economic Times Markets
As per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be credited to their demat accounts and qualify for the bonus issue. This makes today the last day to buy the stock to be eligible for the bonus shares.
The analysis
Buybacks, dividends and splits change what a shareholder actually receives, and often signal how management reads its own value.
Why it matters
- With SEBI involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- Sectors in the story: Pharma & Healthcare.
Pharma & Healthcare
1M +0.2% · 3M -0.7%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Cash rewards coming? PFC, CONCOR, RITES, to Sonata- These firms to announce dividend with Q2 results 2026 this week
Bonus share: Just single issue with record date this week: Pharma firm's free shares with 68% returns since IPO; ratio
Infosys dividend 2026: Record date tomorrow | Know dividend payout, yield, history, returns
NTPC shares rise 3% after Q2 results. Why Jefferies and Nuvama remain bullish
Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma